Overview
- Editors:
-
-
Richard Keefe
-
, Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, USA
Brief and understandable explanations of each scale
Provides rating scales that can be used for the systematic evaluation of patients in standard clinical practice
Written by respected authors in the field of psychiatry
Access this book
Other ways to access
Table of contents (10 chapters)
-
-
- Joseph Ventura, Stephen Marder
Pages 1-8
-
-
- Michael Kraus, Richard Keefe
Pages 15-31
-
-
-
-
-
- Donald Goff, Julie Kreyenbuhl
Pages 65-71
-
- Ashwin A Patkar, Jonathan C Lee
Pages 73-78
-
About this book
This book provides a wealth of assessment instruments from the world’s experts to help clinicians gather the most important information from their patients. This is the 3rd edition of our highly successful guides to Rating Scales in Schizophrenia, it is a practical and quick reference publication for psychiatrists. Â
Editors and Affiliations
-
, Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, USA
Richard Keefe
About the editor
Richard Keefe, PhD, is Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center in Durham, North Carolina. He received his BA from Princeton University and his PhD in clinical psychology from New York University. His research is primarily devoted to understanding cognitive dysfunction and its treatment in patients with schizophrenia and related disorders, including those at high risk for schizophrenia. Dr Keefe has had a leadership role in several large National Institute of Mental Health studies including the CATIE, MATRICS, TURNS, and TENETS projects. He has authored more than 160 peer-reviewed scientific papers and two books. He serves on the editorial boards of several journals, including Schizophrenia Research, Schizophrenia Bulletin, and Innovations in Clinical Neuroscience, and is Associate Editor of Psychological Medicine. He is President of the International Society for CNS Clinical Trials and Methodology for 2012–2014. He is the Founder and CEO of NeuroCog Trials, Inc. He is a Co-Principal Investigator and Director of the Neurocognitive Core for the Translational and Clinical Research Neuroscience project at the Institute of Mental Health in Singapore.Â